Rilutek
Active substance: riluzole
riluzole
Centralised EU authorisationActive
Marketing holder: Sanofi Winthrop Industrie
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 2 | |
| US 10 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-6650-7b35-932e-6ced10e6b7ac;count=1 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-59cb-78fa-8723-2e099cc1aad2,01a1208c-bb82-7835-93a9-610326da75af,01a1208d-6367-7f80-8570-3b739a3737fc,01a1208e-bf3b-7a6f-b6e7-438197a17bd9,01a12092-68da-726c-90c6-adc3df651f73;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000109
- Registration status
- Active
- ATC code
- N07XX02
Sources
- product · EMA · EMEA/H/C/000109 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000109 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000109 · Verified 2026-10-09